Please login to the form below

Not currently logged in
Email:
Password:

Vectura

This page shows the latest Vectura news and features for those working in and with pharma, biotech and healthcare.

Advair generics and acquisitions to hit GSK in 2019

Advair generics and acquisitions to hit GSK in 2019

Novartis’ Sandoz and Hikma/Vectura are set to follow, after delays to the entrants because of the complexity of creating a close copy of GSK’s inhaler.

Latest news

More from news
Approximately 4 fully matching, plus 20 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2016 Deal Watch March 2016

    Licence. $855. SkyePharma/ Vectura. Respiratory Drugs. Merger. $627. Padlock Therapeutics/ BMS.

  • Deal Watch table for March 2014 Deal Watch table for March 2014

    185. Activaero/ Vectura. Acquisition (cash equity). Portfolio of nebuliser-based respiratory products and technologies.

  • Pharma deals during March 2014 Pharma deals during March 2014

    Sales of Actimmune were $58.9m in 2013. Vectura's acquisition of private German company Activaero for $181m in cash and equity brings a smart nebuliser-based technology and three nebuliser ... acquisition expands Vectura's respiratory formulation and

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Christian Pangratz to head up Sterna Biologicals Christian Pangratz to head up Sterna Biologicals

    He joins as CEO having previously served as senior VP for Vectura Group. ... Clinical-stage immunotherapy company Sterna Biologicals has appointed its new chief executive officer in the form of Christian Pangratz, who joins the firm from Vectura Group,

  • Germany's Ventaleon names biotech entrepeneur CEO Germany's Ventaleon names biotech entrepeneur CEO

    Dauer has several years of senior executive management experience serving Activaero - a private German pharma firm now owned by Vectura - as its chief strategy officer and subsequently at Berlin-based OMEICOS

  • Sosei appoints CFO Sosei appoints CFO

    Oakley brings a varied corporate finance career to the firm, most recently having served as chief financial officer of Vectura Group.

  • Silence Therapeutics adds to leadership team Silence Therapeutics adds to leadership team

    He previously held positions at AstraZeneca and PA Technology, and has contributed to the founding of Vectura, Arakis and Chiroscience Group.

  • Kymab names Anne Hyland as chief financial officer Kymab names Anne Hyland as chief financial officer

    Hyland has more than 25 years of financial experience with both public and private firms, most recently serving as chief financial offer (CFO) at BBI Diagnostics and Vectura Group. ... Prior to her 11-year stint at Vectura, Hyland held roles at Medeva as

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Healthcare in a lockdown
Even if patients are getting enough care during the COVID-19 pandemic, are they getting the right care?...
Love in the Time of Coronavirus
Having gone through 4 stages of coping with covid-19: first disbelief, then humour, then creative ways to deal with isolation, and finally the tragic realisation that lives are being lost...
The other side of … multiple sclerosis
No good comes from excluding patients from having a say in their own care. In fact, improving activation (& outcomes) demands it....

Infographics